低分子肝素与普通肝素治疗肺栓塞的疗效

低分子肝素与普通肝素治疗肺栓塞的疗效

刘长福

【期刊名称】《中西医结合心血管病电子杂志》

【年(卷),期】2014(000)009

【摘要】目的：比较低分子肝素与普通肝素治疗肺栓塞的临床疗效。方法选取2012年6月～2014年6月期间我院收治住院的肺栓塞患者60例进行研究分析，随机分为两组，分别使用低分子肝素及普通肝素进行治疗，对比分析其结果。结果肺栓塞患者经过低分子肝素与普通肝素治疗后，两组的临床疗效无明显差异（P＞0.05）。但两组的患者不良反应发生率有明显差异（P＜0.05）。结论低分子肝素因其生物利用度高，不良反应少，且具有稳定的剂量效应，在肺栓塞治疗中更实用、更安全。%Objective Comparing the clinical efifcacy of low-molecule heparin treating pulmonary embolism with those of common heparin. Method Using low-molecule heparin or common heparin to treat 60 patients of pulmonary embolism randomly. The Results were compared and analyzed. Results The treatment efifciencys of the two groups have no signiifcant differences (P>0.05). But the adverse reaction rates in the two groups have got signiifcant difference (P<0.05). Conclusion Because of its high bioavailability, less adverse reaction, and dose stable effect, low molecular weight heparin is more practical and safety in the treatment of pulmonary embolism.

【总页数】2页(13-14)

【关键词】低分子肝素钠;普通肝素;肺栓塞;疗效